Denise Lepley

780 citations
18 papers · 650 indexed · h-index 8
Topics
Ovarian cancer diagnosis and treatment (4 papers)Renal cell carcinoma treatment (3 papers)Cancer Genomics and Diagnostics (3 papers)
Partner nations
United StatesSpainItaly

In The Last Decade

Denise Lepley

16 papers receiving 629 citations

Peers

Denise Lepley
Comparison fields: 5 of 68
  • Molecular Biology 412
  • Oncology 119
  • Cell Biology 109
  • Pharmacology 98
  • Biochemistry 79
Replace Yancun Yin with:
Yancun Yin China
Chang-Hyun Yun South Korea
Zachary R. Healy United States
Linette Castillo‐Pichardo Puerto Rico
Sang‐Hyeok Woo South Korea
Xu Zheng China
Fen-Fen Lin United States
Yuqian Chang China
Matthias P. Kramer Austria
Denise Lepley relative to Yancun Yin China Yancun Yin's profile →
Citations per field
00.5×1.5×
Yancun Yin · 1×
Citations per year

Countries citing papers authored by Denise Lepley

Since Specialization
Citations

This map shows the geographic impact of Denise Lepley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Lepley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Lepley more than expected).

Fields of papers citing papers by Denise Lepley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Lepley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Lepley. The network helps show where Denise Lepley may publish in the future.

Co-authorship network of co-authors of Denise Lepley

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Lepley. A scholar is included among the top collaborators of Denise Lepley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Lepley. Denise Lepley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 0
2 0
3 4
4 4
5 2
6 4
7 1
8 2
9 1
10 11
11 51
12 147
13 60
14 20
15 140
16 4
17
Diet intervention for modifying cancer risk.
43
18 156

About Denise Lepley

Denise Lepley is a scholar working on Reproductive Medicine, Hematology and Cancer Research, having authored 18 papers that have together received 650 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Renal cell carcinoma treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Biochemistry (79 citations), Cell Biology (109 citations) and Molecular Biology (412 citations). Denise Lepley has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Jill C. Pelling, Diane F. Birt, Boyong Li, Jihye Paik, Fernando Ferrer, Timothy Hla, Kathy A. Suprenant, Jenny Devenport, Joel Kremer and Mark C. Genovese. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026